These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1722636)

  • 1. [Clinical evaluation of serum basic fetoprotein in patients with urogenital malignancies and renal transplantation].
    Seguchi T; Sugao H; Takahara S; Nakano E; Ishibashi M; Sonoda T
    Hinyokika Kiyo; 1991 Nov; 37(11):1475-9. PubMed ID: 1722636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (1) Clinical usefulness of BFP].
    Ishii M; Hattori N; Kato T; Mochizuki M; Kamidono S; Sawabu N; Kawada Y; Kawai T; Abe O; Ohkura H
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2107-13. PubMed ID: 2456039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (2) Comparison and combination of BFP with other tumor markers].
    Ishii M; Hattori N; Kato T; Mochizuki M; Kamidono S; Sawabu N; Kawada Y; Kawai T; Abe O; Ohkura H
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2115-23. PubMed ID: 2456040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of serum basic fetoprotein with acute rejection in kidney transplantation.
    Seguchi T; Nakano E; Kameoka H; Takahara S; Namiki M; Ishibashi M; Okuyama A
    Clin Transplant; 1994 Feb; 8(1):30-3. PubMed ID: 8136564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary basic fetoprotein in the diagnosis and follow-up of patients with urothelial carcinoma.
    Kigure T; Wakayama Y; Satoh Y; Fujieda N; Yoshida K; Harada T
    Cancer; 1996 Apr; 77(8):1529-34. PubMed ID: 8608539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical-evaluation of serum basic fetoprotein as a marker in urogenital malignant-tumors.
    Gotoh A; Harada K; Gohji K; Arakawa S; Kamidono S
    Oncol Rep; 1995 Jan; 2(1):49-53. PubMed ID: 21597687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of urinary basic fetoprotein and the BTA test for detection of bladder cancer].
    Imamura M; Inoue K; Megumi Y; Nishimura M; Ohmori K; Nishimura K
    Hinyokika Kiyo; 2000 Oct; 46(10):705-9. PubMed ID: 11215195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Basic fetoprotein (BFP)].
    Ishii M; Seino Y; Urabe T; Hattori N
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1402-9. PubMed ID: 2425742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical investigation of basic fetoprotein (BFP) and carcinoembryonic antigen (CEA) in stomach cancer and lung cancer].
    Kanda Y; Ishii M
    Gan No Rinsho; 1985 May; 31(6 Suppl):600-5. PubMed ID: 2411961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical usefulness of urinary basic fetoprotein (BFP) in patients with urological malignancies].
    Tsujii T; Yonese J; Kojima S; Tari K; Ishii M; Seino Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):829-34. PubMed ID: 1698231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical study on the tumor associated antigen CA50 in the monitoring of genitourinary malignancies].
    Li CL; Xu BZ; Chen ZZ
    Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):148-51. PubMed ID: 7924868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric kidney transplantation is safe and available for patients with urological anomalies as well as those with primary renal diseases.
    Morita K; Iwami D; Hotta K; Shimoda N; Miura M; Watarai Y; Hoshii S; Obikane K; Nakashima T; Sasaki S; Nonomura K
    Pediatr Transplant; 2009 Mar; 13(2):200-5. PubMed ID: 18662371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of serum S100ao protein in patients with urogenital diseases and healthy volunteers].
    Kikuchi T; Morita T; Hashimoto S; Hara Y; Moriguchi H; Ishikawa S; Kobayashi Y; Ishiyama S; Goto K; Tozuka K
    Hinyokika Kiyo; 1990 Oct; 36(10):1117-23. PubMed ID: 2264539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA fragmentation in acute and chronic rejection after renal transplantation.
    Ott U; Aschoff A; Fünfstück R; Jirikowski G; Wolf G
    Transplant Proc; 2007; 39(1):73-7. PubMed ID: 17275477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
    Hamami G
    Hinyokika Kiyo; 1983 Oct; 29(10):1231-45. PubMed ID: 6085711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract].
    Sanada S; Ogura K; Kiriyama T; Yoshida O
    Hinyokika Kiyo; 1985 Aug; 31(8):1299-316. PubMed ID: 4083194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serum tumor necrosis factor alpha and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases.
    Sonkar GK; ; Singh RG
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1000-4. PubMed ID: 19861860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum basic fetoprotein in patients with renal cell carcinoma.
    Gohji K; Ishii M; Nagata H; Matsumoto O; Kamidono S
    Cancer; 1990 Mar; 65(6):1405-11. PubMed ID: 1689608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.